NYS DOH Guidance
|COVID-19 Guidance for Hospital Operators Regarding Visitation: Effective immediately, all hospitals suspend visitation except when medically necessary (i.e., a visitor is essential to the care of the patient) or for family members or legal representatives of patients in imminent end-of-life situations||3/18|
|PUI Guidance: Responding to the revised CDC criteria, DOH issued updated PUI guidance||3/6|
|Dear Administrator Letter: Addresses questions sent to DOH on infection control measures, health care delivery for asymptomatic persons under monitoring, and management of health care personnel with potential exposure in a health care setting||2/25|
|Ensuring Access to Health Care Services During COVID-19: Advises health care providers to continue to ensure infection prevention and control measures are in place and to contact patients who may have missed routine care or follow-up appointments during the COVID-19 public health emergency; outlines strategies to separate well individuals from the sick and reduce transmission among health care personnel, and best practices for contacting patients.||5/19|
|Hospital Access to Hydroxychloroquine and Azithromycin for the Treatment of COVID-19: DOH is working collaboratively with health care practitioners who are treating certain patients hospitalized with COVID-19 to implement scientific studies and research on the efficacy and tolerability of Hydroxylchloroquine and Azithromycin. This Health Advisory outlines conditions of participation in the state-approved, FDA-authorized clinical study.||3/25|
|DOH Advisory on Pediatric Inflammatory Disease Potentially Related to COVID-19: reports that hospitals must immediately report cases of Pediatric Multi-System Inflammatory Syndrome potentially associated with COVID-19 in patients who are under 21 years of age via the Health Emergency Response Data System (HERDS) application on the health commerce system. Hospitals also must perform a diagnostic and serological test to detect the presence of SARS-COV-2, the virus that causes COVID-19, or corresponding antibodies in the patient.||5/6|
|Health Advisory: Provides an interim case definition for Pediatric Multi-System Inflammatory Syndrome Temporally Associated with COVID-19. The Advisory identifies clinical, general laboratory, virologic laboratory, and epidemiologic criteria for case classification.||5/13|
|Multisystem Inflammatory Syndrome in Children (MIS-C): Guidance for Ambulatory Care Providers||6/24|
|COVID-19 Release from Home Isolation: Revised to follow the CDC’s non-test-based strategy||3/28|
|Discontinuation of Isolation for Patients with COVID-19 Who Are Hospitalized or in Nursing Homes, Adult Care Homes, or Other Congregate Settings with Vulnerable Residents: Recommends discontinuation of transmission-based precautions for patients with COVID-19 in these settings when they meet more stringent conditions compared to recent guidance.||4/19|
NJ DOH Guidance
NYC DOHMH Guidance
|COVID-19 Outpatient Infection Control Quick Guide||3/16|
|Guidance for people with increased risk of severe COVID-19||3/8|
|DOH Commissioner order to all educators, first responders, and health care workers employed by NYC||3/5|
|2019 Novel Coronavirus Local Health Department Guidance: Isolation and Quarantine (Please note this items is written for use by local health departments and is being shared with members for informational purposes only)||2/5|
|Interim Movement and Monitoring Guidance for Asymptomatic Persons with Potential Exposure to the 2019 Novel Coronavirus (Please note this items is written for use by local health departments and is being shared with members for informational purposes only)||2/5|
|Summary of Current New York City COVID-19 Guidance for Quarantine, Isolation and Transmission-Based Precautions: examines guidance for non-hospitalized people, including most essential and health care personnel, hospitalized people, immunocompromised people in any setting, residents of long-term care and other congregate living facilities with vulnerable populations, employees of nursing homes and adult care facilities, a person in quarantine due to close contact with someone who has a positive COVID-19 diagnosis, and quarantine or exclusion of health care personnel with exposure at work to a person with a positive COVID-19 diagnostic test.||6/28|
|Health Care Provider Management Checklist for Patients Suspected to Have COVID-19||2/28|
|FAQ About 2019 Novel Coronavirus and COVID-19 for Health Care Providers||6/29|
|Health Advisory #14: Outlines recommendations for the discontinuation of isolation and monitoring for people who are asymptomatic; isolation and transmission-based precautions for people with COVID-19, including non-hospitalized patients; residents and patients in special settings; and people who are immunocompromised||5/14|
|Emergency Medical Treatment and Labor Act (EMTALA) Requirements and Implications Related to COVID-19: Addresses screening obligations and stabilization, transfers, and recipient hospital obligations.||3/30|
|CMS Announces Actions to Address Spread of Coronavirus: Recommends infection control practices for all health care providers.||3/4|
|Guidance for Infection Control and Prevention of COVID-19 in Hospitals, Psychiatric Hospitals, and Critical Access Hospitals: FAQs, Considerations for Patient Triage, Placement, Limits to Visitation and Availability of 1135 waivers.||3/30|
|Guidance for Infection Control and Prevention of COVID-19 in Outpatient Settings: FAQs and Considerations||3/30|
|Guidance for Infection Control and Prevention of COVID-19 in Intermediate Care Facilities for Individuals with Intellectual Disabilities and Psychiatric Residential Treatment Facilities||3/30|
|Guidance for Infection Control and Prevention of COVID-19 in dialysis facilities||3/30|
SONPM National Registry on Infant COVID-19 Infection
The American Academy of Pediatrics Section on Neonatal and Perinatal Medicine (SONPM) is inviting all hospitals that care for infants to participate in a National Perinatal COVID-19 registry by submitting deidentified maternal and neonatal data pertaining to COVID-19. The study aims to gather data to determine the risk of transplacental, perinatal, and post-natal transmission of COVID-19. For more information on the registry, data collected, and how to participate, please contact Mark Hudak, MD, FAAP.
ASPR Guidance on Using CHEMPACK Assets
The US Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) has issued guidance on the use of CHEMPACK assets during the COVID-19 pandemic.
Public Health and Health Planning Council Regulations
New York State’s Public Health and Planning Council released regulations on March 10 clarifying requirements for isolation and quarantine, and updating other areas of the code applicable to local health departments and hospitals during a communicable disease outbreak.
American College of Cardiology Guidance for the Cardiovascular Care Team
The American College of Cardiology released a clinical bulletin containing COVID-19 guidance for the cardiovascular care team. The bulletin contains current COVID-19 clinical context, acute cardiac complications, implications for patients with underlying cardiovascular conditions, and cardiac-specific preparedness recommendations.
ACOG Clinical Updates
The American College of Obstetricians and Gynecologists (ACOG) has collated resources for clinicians treating pregnant COVID-19 patients. Recent updates include updated guidance on frequently asked questions around personal protective equipment (PPE) and pregnant staff members, and how to manage the second stage of labor. A recording of the March 30 joint ACOG and New York State Perinatal Quality Collaborative webinar featuring State faculty discussing treatment protocols and best practices for pregnant COVID-19 patients is available here.